Integrating Epidemiological Data into a Mechanistic Model of Type 2 Diabetes: Validating the Prevalence of Virtual Patients

Mathematical models are playing an increasing role in understanding the complexity of multifactorial diseases like type 2 diabetes. The objective of this study was to validate a population of virtual patients against a real population of patients with type 2 diabetes. A population of virtual patients was created that incorporates different underlying pathogenic lesions consistent with a type 2 diabetic phenotype. These virtual patients were created within the Metabolism PhysioLab platform, a non-linear coupled differential algebraic model that incorporates the salient causal mechanisms underlying glucose homeostasis and substrate metabolism. The weights of each individual virtual patient were determined to reproduce the diversity in a real type 2 diabetic population obtained from the NHANES III study. As a validation test, this virtual population reproduced a series of clinical studies that identify less invasive biomarkers for insulin sensitivity. This approach demonstrates how computational bridges can be constructed between statistical approaches common in epidemiology and deterministic approaches common in biomedical engineering.

[1]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[2]  H. Kaiser.  The Application of Electronic Computers to Factor Analysis , 1960 .

[3]  Aleksandra Galetin,et al.  UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE: IMPACT OF VARIABILITY, CYP3A5, AND CYP2C19 ON CYP3A4 PROBE SUBSTRATES , 2004, Drug Metabolism and Disposition.

[4]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[5]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[6]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[7]  A. Kansal.  Modeling approaches to type 2 diabetes. , 2004, Diabetes technology & therapeutics.

[8]  Claudio Cobelli,et al.  Global identifiability of nonlinear models of biological systems , 2001, IEEE Transactions on Biomedical Engineering.

[9]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .

[10]  A. Vaag,et al.  A Simple Method for Quantitation of Insulin Sensitivity and Insulin Release from an Intravenous Glucose Tolerance Test , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[11]  J. Pearl.  Causality: Models, Reasoning and Inference , 2000 .

[12]  C. Pichard,et al.  Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. , 2001, Nutrition.

[13]  David M Eddy,et al.  Archimedes: a trial-validated model of diabetes. , 2003, Diabetes care.

[14]  Ravindra Khattree,et al.  Multivariate Data Reduction and Discrimination With SAS® Software , 2001 .

[15]  K. Frayn.  Metabolic Regulation: A Human Perspective , 1996 .

[16]  Kiyomi Ito,et al.  UTILITY OF RECOMBINANT ENZYME KINETICS IN PREDICTION OF HUMAN CLEARANCE : IMPACT OF VARIABILITY , CYP 3 A 5 , AND CYP 2 C 19 ON CYP 3 A 4 PROBE SUBSTRATES , 2004 .

[17]  H. Koyama,et al.  Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[19]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[20]  A. Baron,et al.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.

[21]  R. Ross,et al.  Estimation of skeletal muscle mass by bioelectrical impedance analysis. , 2000, Journal of applied physiology.

[22]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[23]  K. Petersen,et al.  Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. , 2001, Diabetes.

[24]  A. Kansal,et al.  Application of predictive biosimulation within pharmaceutical clinical development: examples of significance for translational medicine and clinical trial design. , 2005, Systems biology.

[25]  W. Winter,et al.  A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[26]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[27]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.

[28]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[29]  David M Eddy,et al.  Validation of the archimedes diabetes model. , 2003, Diabetes care.

[30]  Ping Zhang,et al.  Guidelines for computer modeling of diabetes and its complications , 2004 .

[31]  M. Camilleri,et al.  Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[32]  K. Petersen,et al.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. , 1998, The Journal of clinical investigation.

[33]  M. Stumvoll.  Control of glycaemia: from molecules to men. Minkowski Lecture 2003 , 2004, Diabetologia.

[34]  Ádám M. Halász,et al.  Understanding the Bacterial Stringent Response Using Reachability Analysis of Hybrid Systems , 2004, HSCC.

[35]  Jon Wakefield,et al.  Population modelling in drug development , 1999, Statistical methods in medical research.

[36]  Meindert Danhof,et al.  Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. , 2007, Annual review of pharmacology and toxicology.

[37]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[38]  I. Jolliffe.  Rotation of principal components: choice of normalization constraints , 1995 .

[39]  J. Holst,et al.  Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. , 1996, Metabolism: clinical and experimental.

[40]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[41]  J A Jacquez,et al.  Parameter estimation: local identifiability of parameters. , 1990, The American journal of physiology.